Last updated: 4 months ago
Citius Pharmaceuticals (CTXR) Q4 2024 Financial Report: Challenges & Future Outlook
Explore Citius Pharmaceuticals' Q4 2024 financial report highlighting significant losses, R&D investments, and a cautious hold recommendation for investors navigating a complex market.